IL2 and inflammatory bowel disease: Non-HLA findings include modifications in genes related to autoimmunity (IL2/IL2RA), bile acid toxicity (GPBAR1), and mechanisms related to concomitant IBD (IL2/IL21, ILR2A, CARD9, MST1, Fut2, and SIK2) [27, 46].